Efficient Drug Development
TNO works with public and private parties to create and implement innovative technologies that make the process of drug development – from laboratory to patient – more efficient. This will make it possible to cut development costs and to get drugs to patients sooner.

Our latest developments
22 resultaten, getoond 1 t/m 5
Obesity
Advance obesity drug development with TNO’s translational Ldlr−/−.Leiden mouse model. Generate clinically relevant, multi-organ efficacy data with AI-supported analysis that closely aligns with human outcomes.


Diabetic kidney disease


Liver (MASLD-MASH and liver fibrosis)



